Revenue from Japan, page-16

You are correct. The graph is in the link you posted. Cheers! After 100 days all three categories completely plateaued. I wonder how long term it is, it would be fantastic if it was years or decades!

That dramatically changes the cost/benefit profile. I never realised how good the results were. Apologies for my ignorance, I don't follow msb for GvHD. My earlier statement still stands, there will still be a slow up take but as confidence grows it should set the stage for a good long term global therapy.

Honestly, I hang around the msb forum for the CHF therapy. That to me is the game maker or game breaker. GvHD is a small market but still valuable to msb and even more so to the patients and their families.